Facebook Linkedin Youtube X-twitter Instagram
Professional Syndicates Complex, Sharif Abdel Hamid Sharaf Street, 31, Amman, Jordan
About Jordan
  • Home
  • Membership
    • Membership Request
    • Associate Members
    • Types of memberships
    • General Payment Service via Cliq
  • Activity
    • Lectures and conferences
  • Health Education
  • Scientific materials
  • Gallary
    • Videos
    • Photos
  • About US
  • Contact us
  • English
Login
  • Home
  • Membership
    • Membership Request
    • Associate Members
    • Types of memberships
    • General Payment Service via Cliq
  • Activity
    • Lectures and conferences
  • Health Education
  • Scientific materials
  • Gallary
    • Videos
    • Photos
  • About US
  • Contact us
  • English
  • من نحن
    • تاريخ الجمعية
    • هيكل الجمعية
    • ادارة الجمعية
    • تطوع معنا
  • العضوية
    • طلب انتساب
    • الاعضاء المنتسبون
    • Types of memberships in the Society of Cardiologists
  • Home
  • نشاطات
  • مواد علمية
  • Health Education
  • جاليري
    • فيديو
    • صور
  • اتصل بنا
Uncategorized
jordan heart December 9, 2025 0

Potassium-Enriched Salt in Hypertension Management (Hypertension News, Dec 2025)

Potassium-Enriched Salt in Hypertension Management (Hypertension News, Dec 2025)
1.⁠ ⁠Background: Why Potassium-Enriched Salt?
• High sodium intake remains a major global driver of hypertension, CVD, and premature death.
• No country is on track to meet WHO salt-reduction targets (2025/2030).
• Low potassium intake is an under-recognized but equally important BP risk factor.
• Most populations consume far below the WHO potassium recommendation (3.5 g/day).
2.⁠ ⁠What Is Potassium-Enriched Salt?
• Regular salt with part of NaCl replaced by KCl (e.g., 75% NaCl / 25% KCl).
• Maintains salty taste → increases acceptability.
• Available as “Lo Salt,” “Lite Salt,” “Heart Salt,” etc.
• Designed for 1:1 replacement with regular salt.
3.⁠ ⁠Evidence for BP & Cardiovascular Benefit
• Dual mechanism: ↓ sodium intake + ↑ potassium intake.
• Strong evidence from systematic reviews and the landmark SSaSS Trial (NEJM) showing:
✔ Lower BP
✔ Fewer strokes
✔ Reduced cardiovascular events and mortality
• WHO 2025 Global Hypertension Report formally recommends potassium-enriched salt.
4.⁠ ⁠Guideline Positioning (2024–2025)
• Historically underrepresented: only 4 of 32 guidelines mentioned salt substitutes (2024 review).
• Now explicitly recommended by:
✔ 2024 ESC Hypertension Guidelines
✔ 2025 ACC/AHA Hypertension Guidelines
• Growing international endorsement.
5.⁠ ⁠Safety and Hyperkalemia Concerns
• Main concern: potential hyperkalemia in patients with CKD, or those on
•⁠  ⁠potassium supplements
•⁠  ⁠potassium-sparing diuretics
• Trials show:
•⁠  ⁠No increase in clinical harm, even in CKD-inclusive studies.
•⁠  ⁠Some biochemical hyperkalemia noted, but CV benefits remained.
• RAAS inhibitors do not increase hyperkalemia risk when kidney function is normal.
6.⁠ ⁠Practical Clinical Recommendations
Safe Use (per Xu et al.):
• Recommend 1:1 switch to potassium-enriched salt unless:
•⁠  ⁠moderate/severe CKD (Stage ≥3)
•⁠  ⁠using K supplements or K-sparing diuretics
•⁠  ⁠other hyperkalemia risk factors
• Check kidney function when feasible.
• OK in mild CKD (Stage 1–2) with caution during acute illness.
• Encourage diet rich in fruit & vegetables.
7.⁠ ⁠Public Health Impact
• Population-wide adoption could prevent ~3 million deaths annually (modeling study).
• Represents a practical, scalable lifestyle intervention with substantial global benefit.
8.⁠ ⁠Key Message
Potassium-enriched salt is a simple, evidence-based, high-impact strategy for lowering BP and reducing cardiovascular risk — now endorsed by major hypertension guidelines and recommended for most patients without hyperkalemia risk.
https://ish-world.com/document/1764854372.pdf
16 Views
2
BIHS 2025 Position Statement on BP Treatment Thresholds and TargetsDecember 9, 2025
Why Heart Failure Protocols Matter: Global Evidence That GDMT Underuse Is a Worldwide Problem (2025)December 9, 2025

مقالات ذات صلة

Uncategorized

Mitral Valve Disease in 2025: Evolving Treatment Pathways from ESC Guidelines and TCT Advances

jordan heart November 3, 2025
Uncategorized

First AHA-Approved Heart Failure Center Certified Outside the U.S.!

jordan heart October 21, 2025

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

احدث المقالات

  • Proposed National System for Early Identification and Diagnosis of Heart Failure in Jordan
  • HFpEF: Common Disease, Uncommon Diagnosis
  • Proposed National System for Early Identification and Diagnosis of Heart Failure in Jordan
  • Why Heart Failure Protocols Matter: Global Evidence That GDMT Underuse Is a Worldwide Problem (2025)
  • Potassium-Enriched Salt in Hypertension Management (Hypertension News, Dec 2025)

فئات

  • Health Education
  • Previous lectures and conferences
  • Uncategorized

Jordanian Cardiology Society

Jordanian Cardiology Society

Amman-Jordan

00962795001983

Working hours

From Sunday to Thursday

From nine in the morning until four in the afternoon

Important Links

Jordanian Cardiology Society

Research and studies

Medical articles

Login

Privacy Policy

Refund Policy

Cancellation Policy

Delivery Policy

Association Location

Copyright © 2024 Jordanian Cardiologists Association by WebAppRoots. All Rights Reserved.